NASDAQ Composite ended the session with Catalyst Pharmaceuticals jumping 2.08% to $3.56 on Tuesday, following last session’s downward trend. NASDAQ Composite rose 1.57% to $13,202.40, after two consecutive sessions in a row of losses, on what was an all-around positive trend trading session today.

Catalyst Pharmaceuticals today’s close was $3.56, 48.20% below its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 0.8% for the current quarter and 5.5% for the next. The company’s growth estimates for the current quarter is 12.5% and a drop 20% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.


Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was a negative 1.15%, a positive 0.06%, and a negative 0.44%, respectively.

Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 2.87%, 3.55%, and 4.34%, respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $3.56 at 16:34 EST, way under its 52-week high of $5.28 and way higher than its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is higher than its 50-day moving average of $3.54 and below its 200-day moving average of $3.61.


Please enter your comment!
Please enter your name here